Search

everythinglearnresearchcommunity

for

Search:↓

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

A document listed serious side effects from various drugs, including deaths and diseases, emphasizing the importance of being aware of drug side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Lespedeza cuneata extract may help treat enlarged prostate.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Uterine transplants for transgender women are feasible but need more research.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Testosterone reduces heart damage and inflammation after injury.